It employs about 60 workers and plans to have 100 on staff next year. The company recently expanded into a 40,000 square foot research and development building in Sorrento Mesa. Food and Drug Administration to review for its continuous glucose monitor, citing competitive reasons. Yang also wouldn’t say when the company plans to submit data to the U.S. The company has received grants from the federal government and strategic investors to fund develop of biosensors that detect markers beyond glucose, said Yang. Prior to this latest funding, it raised $15.95 million. The sensors last about two weeks before replacement.īiolinq borrows from semiconductor industry to miniaturize electrochemical sensors, which can be manufactured at scale to keep costs down, according to the company. Today’s glucose monitors require a sensor to be placed under the skin with an applicator, or needle.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |